TK1 and breast carcinoma: The discrepancies between TK1 activity and protein-elution profiles were even more apparent in sera from breast and prostate cancer patients, where STK1 activity was primarily observed as an active high-MW complex, whereas the TK1 polypeptide was observed in almost all serum fractions in breast cancer.